Est. 2001·3,000+ placements · six offices · four regions
Partnershipcurated sourcedetected 2026-04-16 · confidence 80%

Last updated

Ferring Pharmaceuticals: Partnership

Partnership with Gallup to launch global fertility attitudes study across 70 countries as part of Gallup World Poll

Source: Financial Post

What happened
Partnership with Gallup to launch global fertility attitudes study across 70 countries as part of Gallup World Poll
Who
Ferring Pharmaceuticals · EMEA (ex UK)
When
2026-04-16
So what
Ferring has committed to something more durable than a single study: a standing, multi-wave data asset on fertility attitudes tied to the infrastructure of the Gallup World Poll across 70 countries.

The leadership read

Ferring has committed to something more durable than a single study: a standing, multi-wave data asset on fertility attitudes tied to the infrastructure of the Gallup World Poll across 70 countries. That creates a proprietary evidence base it did not hold before, one it can deploy in regulatory conversations, payer negotiations, and policy engagements in markets where fertility treatment reimbursement is contested or absent. The operational weight is in the long tail: managing a research program of this geographic scope requires structured relationships with health ministries, patient advocacy bodies, and demographic research institutions across EMEA and beyond, none of which are legacy pharma competencies. The related signals for this period are thin on true comparables; this is one of twelve partnership signals tracked in the last 90 days, but the set is dominated by brand ambassadorships, infrastructure JVs, and sports-media deals. There are no direct analogues in life sciences or women's health within that window. That absence is itself a read: Ferring is moving into a space, evidence-generation as a commercial and policy instrument, where the competitive field is sparse and the signal pattern has no immediate peer cluster. Companies operating at this intersection of life sciences and population-level policy data face rising demand for leadership in public affairs, health economics, and evidence strategy, specifically operators who can translate longitudinal survey data into reimbursement arguments and legislative positioning across fragmented regulatory environments.

Market context: MitchelLake's Talent Market Index sits at 122.7 (Hot), up 17.8 on the prior month; EMEA hiring signal is running easing (-17.7pts).

Ferring Pharmaceuticals: 0 signals in the last 90 days.

MitchelLake in this thematic

More signals across EMEA

Partnership · EMEA

ClearSpace UK →

UK Space Agency selected ClearSpace UK to lead its Active Debris Removal Mission, backed by more than £60 million in UK government funding. The mission would remove two UK-registered satellites from Low Earth Orbit, with clean-up starting in 2029 and disposal completed by 2032.

Partnership · EMEA

Solana Mobile →

Solana Mobile announced Ledger as its first external hardware partner, bringing its Seeker application and Solana dApp Store access to Ledger's upcoming Atom security device. The announcement was made at Ledger's October event in Paris.

Partnership · EMEA

ORIC Pharmaceuticals →

ORIC Pharmaceuticals signed a collaboration with Cancer Research UK to move its CIP2A-targeted candidate ORIC-259 into early clinical development, with Cancer Research UK funding and running the initial studies.

Partnership · EMEA

Nel →

Norway-based Nel signed a Memorandum of Understanding with Rheinmetall AG to explore joint decentralised renewable fuel production, combining Nel electrolysers with Rheinmetall's Giga PtX concept for modular low-carbon synthetic fuels aimed at defence and critical infrastructure.

Partnership · EMEA

ITM Power →

UK-based ITM Power, via its build-own-operate subsidiary Hydropulse, signed Heads of Terms with a European oil refinery for a 150 MW green hydrogen project using ITM's Alpha electrolyser platform under a 10-year agreement. Parties target FID in 2027 with production from 2029.

Partnership · EMEA

STX Group →

Amsterdam-headquartered commodity trader STX Group took its first offtake of RFNBO-compliant e-methane produced by Turn2X at its first commercial plant in Spain, with first delivery in early October 2026 and active talks on future commercial-scale e-methane projects.

Where this lands in our work

Weekly briefing

Track companies like Ferring Pharmaceuticals — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗